Engineering Fundamentals in Life Science | |||
Session 282 - Gene Therapy and Delivery (II) | |||
This session will be devoted to the development of improved methods of gene transfer using both viral and non-viral approaches. Topics of interest include, but not limited to design of novel formulations for improved gene delivery, determination of rate-limiting steps of gene transfer, targeting of gene transfer vectors, methods for production and purification of viral and non-viral vectors and gene transfer to stem cells for tissue engineering applications. This session has been very well attended in previous years. | |||
Chair: | Stelios T. Andreadis | ||
CoChair: | Joseph M. Le Doux | ||
282a | Immunization Via Skin Using Vaccine-Coated Microneedles Harvinder S. Gill, Jonas Soderholm, Ioanna Skountzou, Joshy Jacob, Richard Compans, Matti Sallberg, Mark R. Prausnitz | ||
282b | Construction of Hybrid Viral/Synthetic Gene Delivery Nanovectors Josh Ramsey, Halong Vu, Daniel W. Pack | ||
282c | Using RNA Interference to Probe Mechanism: Dnase II Is Not Rate Limiting in Non-Viral Gene Transfer to Endothelium Gregory A. Barker, Scott L. Diamond | ||
282d | Egf Ligands Decrease Retroviral Gene Transfer through Protein Kinase C-Delta Raghvendra Singh, Stelios T. Andreadis | ||
Break | |||
282e | Expression-Targeted Gene Therapy for the Treatment of Transitional Cell Carcinoma Xiujuan Zhang, Anthony J. Atala, W. T. Godbey | ||
282f | Analysis of Retroviral Decay: Protein and RNA Stability Monica Casali, Jonathan Goldwasser, Z. Larkin Kelley, Zaki Megeed, Martin L. Yarmush | ||
282g | Engineering Outer Membrane Vesicles for Gene Delivery David Chen, Jae-Young Kim, Anne Doody, Matthew Delisa, David Putnam |
See more of Food, Pharmaceutical & Bioengineering Division